2024-12-11 - Analysis Report
## UnitedHealth Group Inc. (UNH) Stock Analysis Report

**1. Performance Comparison & Divergence:**

UnitedHealth Group Inc. (UNH) is a diversified healthcare company offering a range of health benefits programs and services.  Over the measured period, UNH's cumulative return (161.90%) significantly outperformed the S&P 500 (VOO) cumulative return (120.40%).  The final difference in cumulative returns is 41.5%, placing it at the 32.6th percentile of its historical range of divergence from the S&P 500 (max: 135.8%, min: -4.2%).  While this shows strong outperformance, the relative divergence indicates this level of outperformance is not unprecedented.


**2. Recent Price Movement:**

* **Closing Price:** $565.19
* **5-Day Moving Average:** $571.71
* **20-Day Moving Average:** $591.53
* **60-Day Moving Average:** $582.02

The stock price is currently trading below its 5, 20, and 60-day moving averages, suggesting a short-term downtrend.  The difference between the last market price (565.37) and the closing price is negligible.  There's no indication of a significant recent price jump or drop.


**3. Technical Indicators & Expected Return:**

* **RSI:** 46.60 –  Approaching oversold territory (below 50), suggesting potential for a price bounce.
* **PPO:** -0.95 – Negative value indicates bearish momentum.
* **Delta_Previous_Relative_Divergence (20-day):** -12.3% –  Shows a recent decrease in relative strength compared to the S&P 500.
* **Expected Return (2+ years):** 207.7% –  This suggests significantly higher returns than the S&P 500 over the long term if the current trends continue.  However, this is a projection and not a guaranteed outcome.


**4. Recent Earnings Analysis:**

The provided earnings data shows some volatility:

* **Revenue:** Revenue generally increased QoQ, except for a slight dip in Q2 2024.  Overall, revenue shows a growth trend.
* **EPS:**  Significant fluctuation is observed. Q1 2024 shows a negative EPS, followed by strong positive EPS in subsequent quarters. This variability needs further investigation to identify underlying causes.  Without access to analyst expectations, it's impossible to determine if these results beat or missed expectations.


**5. Financial Information Analysis:**

* **Revenue and Profitability:** Revenue remains relatively stable, while profit margins have shown some fluctuation, but generally remain high.
* **Capital and Profitability:** Equity shows an upward trend, although ROE exhibits considerable volatility, including a negative value in Q1 2024.


**6. News and Recent Issues:**

No recent news (within the last two days) is provided.  Information on market outlook, analyst opinions, and performance highlights is missing.


**7. Overall Analysis:**

UNH has shown significant outperformance against the S&P 500 over the measured period. However, recent price action and technical indicators suggest a short-term downtrend.  While the long-term expected return is high, it is crucial to acknowledge the inherent risks and volatility associated with the healthcare sector and individual stock investments. The recent earnings report indicates strong revenue growth but fluctuating EPS, demanding a deeper understanding of the factors driving this variability.  Further research into recent news, analyst ratings, and a comparison against earnings expectations would significantly enhance the analysis.  The high volatility in ROE also necessitates a closer examination of the company's financial health and risk profile.


**8. Disclaimer:** This report is for informational purposes only and should not be considered investment advice.  Investing involves risk, and past performance is not indicative of future results.  Conduct thorough due diligence before making any investment decisions.  Consult with a qualified financial advisor for personalized advice.
